In recent years, lung transplantation (LT) has been considered to be the most effective treatment method for increasing the quality of life and survival rates in patients with end-stage pulmonary disease. Anesthesiologists can encounter some difficulties in patients undergoing LT. It has been established that induction of anesthesia, positive pressure ventilation, achievement and maintenance of one lung ventilation, clamping and declamping of the pulmonary artery and reperfusion of the transplanted lung were the critical stages when problems tended to occur. Therefore, thorough knowledge of the pathologic physiology of the end-stage pulmonary disease as well as full understanding and adequate management of the specific stages of surgery are...
A left lung allotransplantation was performed on a 42-year-old man dying from hypertrophic emphysema...
The combined transplantation of a thoracic organ and the liver is performed in patients with dual-or...
For patients with end-stage lung disease, LTx remains the only therapeutic option toward better chan...
Anesthesia for lung transplantation: intraoperative complications and long term results. 52 patients...
BACKGROUND: Anesthesia for lung transplantation: intraoperative complications and long term results....
The recent success of the Toronto Lung Trans-plant Group with isolated human lung trans-plantation [...
Since the first lung transplantation, developments in surgical techniques, immunosuppressants, prese...
Abstract Background General theory of anesthetic managements for nontransplant procedures in lung tr...
We highlight the difficulties in managing anaesthesia for post-double lung transplantation patients ...
Lung transplantation has become an accepted option for many patients with end-stage pulmonary diseas...
The management of lung transplant patients has continued to evolve in recent years. The year 2021 wa...
International audienceThe first successful single-lung and double-lung transplantations were perform...
Purpose: We examined the clinical course of anesthetic induction in lung transplant recipients with ...
Lungs transplantation is a solution for the end stage of pulmonary disease after other therapeutic p...
A 43-year-old woman with pulmonary fibrosis secondary to pulmonary alveolar proteinosis was schedule...
A left lung allotransplantation was performed on a 42-year-old man dying from hypertrophic emphysema...
The combined transplantation of a thoracic organ and the liver is performed in patients with dual-or...
For patients with end-stage lung disease, LTx remains the only therapeutic option toward better chan...
Anesthesia for lung transplantation: intraoperative complications and long term results. 52 patients...
BACKGROUND: Anesthesia for lung transplantation: intraoperative complications and long term results....
The recent success of the Toronto Lung Trans-plant Group with isolated human lung trans-plantation [...
Since the first lung transplantation, developments in surgical techniques, immunosuppressants, prese...
Abstract Background General theory of anesthetic managements for nontransplant procedures in lung tr...
We highlight the difficulties in managing anaesthesia for post-double lung transplantation patients ...
Lung transplantation has become an accepted option for many patients with end-stage pulmonary diseas...
The management of lung transplant patients has continued to evolve in recent years. The year 2021 wa...
International audienceThe first successful single-lung and double-lung transplantations were perform...
Purpose: We examined the clinical course of anesthetic induction in lung transplant recipients with ...
Lungs transplantation is a solution for the end stage of pulmonary disease after other therapeutic p...
A 43-year-old woman with pulmonary fibrosis secondary to pulmonary alveolar proteinosis was schedule...
A left lung allotransplantation was performed on a 42-year-old man dying from hypertrophic emphysema...
The combined transplantation of a thoracic organ and the liver is performed in patients with dual-or...
For patients with end-stage lung disease, LTx remains the only therapeutic option toward better chan...